Tianbo Jiang

Internal Medicine

550 1st Ave
New York, NY 10016

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2 publications

BCMA-targeted immunotherapy for multiple myeloma.

BCMA-targeted immunotherapy for multiple myeloma.

Journal: Journal of hematology & oncology

Published: May 02, 2020

A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells.

A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells.

Journal: Blood

Published: October 08, 2015

Showing 1-2 of 2

Last Updated: 09/26/2026